Back to Search
Start Over
Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.
- Source :
-
Mutation research [Mutat Res] 1995 May; Vol. 328 (2), pp. 151-61. - Publication Year :
- 1995
-
Abstract
- Eukaryotic topoisomerase II (Topo-II) inhibitors such as etoposide, adriamycin and mitoxantrone, which commonly stabilize the cleavable complex of the enzyme and DNA, have been found to efficiently induce chromosome-type aberrations (mainly breaks and exchanges) in cultured Chinese hamster lung fibroblastic cells (CHL cells). To clarify whether the induction of chromosome-type aberrations is mediated by stabilization of the cleavable complex, the present study investigated (1) the correlation between the induction of chromosome-type aberrations and the amount of cleavable complex formed; and (2) the ATP dependence of the Topo-II inhibitor-induced chromosome-type aberrations due to the ATP requirement of cleavable complex formation by Topo-II. First, in cells treated with the Topo-II inhibitors, (etoposide, adriamycin) and aclarubicin, an antagonist of the inhibitor of cleavable complex formation, the frequency of chromosome-type aberrations decreased dose-dependently with aclarubicin, in contrast to an increase of chromatid-type aberrations. The formation of the cleavable complex was further established by a proteinase K/SDS precipitation assay for cleaved double-strand DNA in a cell-free system and in CHL cells. Results from both experiments showed that aclarubicin caused a dose-dependent suppression of the accumulation of the cleavable complex induced by etoposide, which corresponded particularly well to the reduction of chromosome-type aberrations in etoposide-treated cells. In ATP-depleted cells simultaneously treated with etoposide and dinitrophenol (DNP), chromosome-type aberrations were reduced as compared with DNP-untreated cells, in contrast to an increase of chromatid exchanges in the cells. This means that etoposide-induced chromosome-type aberrations in ATP-depleted cells may be attributable to incompleteness of Topo-II activities to form DNA double-strand breaks. The present findings indicate that the stabilization of the cleavable complex on Topo-II is closely associated with the induction of chromosome-type aberrations.
- Subjects :
- 2,4-Dinitrophenol
Aclarubicin pharmacology
Adenosine Triphosphate metabolism
Animals
Camptothecin antagonists & inhibitors
Camptothecin toxicity
Cells, Cultured
Cricetinae
DNA Topoisomerases, Type II metabolism
Dinitrophenols pharmacology
Doxorubicin antagonists & inhibitors
Doxorubicin toxicity
Etoposide antagonists & inhibitors
Etoposide toxicity
Fibroblasts drug effects
Chromosome Aberrations
DNA drug effects
DNA Damage
Topoisomerase II Inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 0027-5107
- Volume :
- 328
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Mutation research
- Publication Type :
- Academic Journal
- Accession number :
- 7739599
- Full Text :
- https://doi.org/10.1016/0027-5107(95)00005-4